← Evidence map

ArticleTranslational cancer research2025

Preliminary study of apatinib combined with fluzoparib in the treatment of HRP ovarian cancer via the HR pathway.

Lei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40386258